Anesh Panchal

751 total citations
6 papers, 196 citations indexed

About

Anesh Panchal is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Anesh Panchal has authored 6 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Anesh Panchal's work include Monoclonal and Polyclonal Antibodies Research (4 papers), CAR-T cell therapy research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Anesh Panchal is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), CAR-T cell therapy research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Anesh Panchal collaborates with scholars based in United Kingdom, Spain and Italy. Anesh Panchal's co-authors include Laura Buckley, Rupesh I. Bhatt, Vijay Sangar, John D. Kelly, Martin Hutchings, Sanjeev Madaan, Lucinda Billingham, Adam Devall, Ann Pope and Mark Feneley and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Urology.

In The Last Decade

Anesh Panchal

6 papers receiving 195 citations

Peers

Countries citing papers authored by Anesh Panchal

Since Specialization

Citations

This map shows the geographic impact of Anesh Panchal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anesh Panchal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anesh Panchal more than expected).

Fields of papers citing papers by Anesh Panchal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anesh Panchal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anesh Panchal. The network helps show where Anesh Panchal may publish in the future.

Co-authorship network of co-authors of Anesh Panchal

This figure shows the co-authorship network connecting the top 25 collaborators of Anesh Panchal. A scholar is included among the top collaborators of Anesh Panchal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anesh Panchal. Anesh Panchal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Amivantamab plus lazertinib vs osimertinib in first-line EGFR-mutant advanced non-small cell lung cancer (NSCLC) with biomarkers of high-risk disease: A secondary analysis from the phase 3 MARIPOSA study. 2024 ·Journal of Clinical Oncology ·Enriqueta Felip, Byoung Chul Cho, Vanesa Gutiérrez, Adlinda Alip, Benjamin Besse, (unknown), Alexander I. Spira, Nicolas Girard, Raffaele Califano, Shirish M. Gadgeel, James Chih‐Hsin Yang, Naoyuki Nogami, Koichi Azuma, Joshua C. Curtin, (unknown), Anesh Panchal, (unknown), Seema Sethi, Joshua Bauml, Se‐Hoon Lee	8
2	Glofitamab As Monotherapy and in Combination with Obinutuzumab Induces High Complete Response Rates in Patients (pts) with Multiple Relapsed or Refractory (R/R) Follicular Lymphoma (FL) 2021 ·Blood ·Franck Morschhauser, Carmelo Carlo‐Stella, Michael Dickinson, Tycel Phillips, Roch Houot, Fritz Offner, Corinne Haïoun, Paolo Corradini, Martin Hutchings, Anna Sureda, Joaquín Martínez‐López, Tomasz Wróbel, Shang‐Ju Wu, Linda Lundberg, (unknown), David Pérez-Callejo, James Relf, Anesh Panchal, Kathryn Humphrey, Emmanuel Bachy	20
3	Glofitamab Plus R-CHOP Induces High Response Rates with Minimal Cytokine Release Syndrome (CRS) in Patients (pts) with Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and Previously Untreated (1L) Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results from a Dose-Escalation and Safety Run-in Phase Ib Study 2021 ·Blood ·Nilanjan Ghosh, William Townsend, Michael Dickinson, Max S. Topp, Monica Tani, Armando Santoro, Michael Crump, Franck Morschhauser, Steven Le Gouill, Amitkumar Mehta, Anesh Panchal, Wu Chun, Martin Barrett, Kathryn Humphrey, Naseer Qayum, Martin Hutchings	10
4	Glofitamab (Glofit) in Combination with Polatuzumab Vedotin (Pola): Phase Ib/II Preliminary Data Support Manageable Safety and Encouraging Efficacy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) 2021 ·Blood ·Martin Hutchings, Anna Sureda, María José Terol, (unknown), Paolo Corradini, Thomas Stauffer Larsen, Antonio Rueda‐Domínguez, Anesh Panchal, Alessia Bottos, David Carlile, Yanjie Wang, (unknown), Maneesh Tandon, Gila Sellam, Giuseppe Gritti	31
5	CD20-TCB, a Novel T-Cell-Engaging Bispecific Antibody, Can be Safely Combined with the Anti-PD-L1 Antibody Atezolizumab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma 2019 ·Blood ·Martin Hutchings, Giuseppe Gritti, Anna Sureda, María José Terol, Martin J.S. Dyer, Gloria Iacoboni, William Townsend, Marina Bacac, Ann-Marie E Bröske, Natalie Dimier, Cristiano Ferlini, K. Abiraj, Angelika Lahr, Katharina Lechner, Tom Moore, Peter N. Morcos, Anesh Panchal, Maja Weisser, (unknown)	20
6	Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non–muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial 2018 ·European Urology ·Wei Shen Tan, Anesh Panchal, Laura Buckley, Adam Devall, Laurence Loubière, Ann Pope, Mark Feneley, Jo Cresswell, Rami Issa, Hugh Mostafid, Sanjeev Madaan, Rupesh I. Bhatt, John McGrath, Vijay Sangar, T.R. Leyshon Griffiths, Toby Page, (unknown), (unknown), Lucinda Billingham, John D. Kelly	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact